Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial. The news comes after …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

